#Flash: Gut Microbes Can Improve Prognosis of Rheumatoid Art
A study looked at the gut microbiota of RA patients to see if there were any traits that were linked to, or predicted, a minimum clinically meaningful improvement (MCII) in disease activity. Study was conducted on 64 stool samples of 32 RA patients and the Clinical Disease Activity Index (CDAI) of each patient was measured. The findings revealed that one of the key factors influencing compositional variance in the gut microbiome was age. At both baseline and follow-up visits, patients who improved clinically exhibited more alpha-diversity of microbes in their gut microbiomes. Hence, modifying the gut microbiome to enhance clinical outcome may hold a promising future in RA treatment.

If you find this research insightful, please like, comment and share.

For more details, please read:
https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-021-00957-0#Abs1
1 share
Like
Comment
Share